Globus Medical, Inc. GMED reported fourth-quarter 2024 adjusted earnings per share (EPS) of 84 cents, which beat the Zacks ...

Welcome to the Globus Medical's fourth quarter and full year 2024 earnings call. At this time, all lines will be on mute, and ...

Globus Medical (NYSE:GMED) shares dipped today despite fourth-quarter results that came in ahead of the consensus forecast.

In a report released today, David Turkaly from JMP Securities reiterated a Hold rating on Globus Medical (GMED – Research Report). The ...

Wells Fargo analyst Vik Chopra lowered the firm’s price target on Globus Medical (GMED) to $93 from $95 and keeps an Overweight rating on the ...

Globus Medical saw a strong 2024 with multiple new product launches and more innovation is on the way, President and CEO Dan Scavilla said in a Feb. 20 earnings ...

Q4 2024 Management View CEO Daniel Scavilla highlighted record revenue of $2.519 billion for 2024, driven by $951 million in growth and a 61% increase versus the prior year. Non-GAAP EPS for the year ...

Portman Ridge Finance Corporation (NASDAQ: PTMN ) Click to Take Action Portman Ridge Finance Corporation has agreed to be acquired by Logan Ridge Finance Corporation. Under the proposed agreement, ...

Medical technologies specialist Globus Medical(NYSE:GMED) reported impressive results for the fourth quarter of 2024 on Thursday, Feb. 20. The highlights included adjusted earnings per share (EPS) of ...

The global Orthobiologics Market is valued at $6.56 billion in 2024 and is projected to reach a value of $10.4 billion by ...